Bartlett & Co Wealth Management’s Lennox International LII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15K Sell
2
-7
-78% -$3.56K ﹤0.01% 1206
2026
Q1
$4.63K Hold
9
﹤0.01% 1028
2025
Q4
$4.38K Hold
9
﹤0.01% 1031
2025
Q3
$4.78K Hold
9
﹤0.01% 1012
2025
Q2
$5.17K Hold
9
﹤0.01% 996
2025
Q1
$5.05K Hold
9
﹤0.01% 987
2024
Q4
$5.49K Hold
9
﹤0.01% 962
2024
Q3
$5.45K Hold
9
﹤0.01% 968
2024
Q2
$4.83K Hold
9
﹤0.01% 986
2024
Q1
$4.41K Sell
9
-1,317
-99% -$599K ﹤0.01% 982
2023
Q4
$595K Buy
1,326
+1,317
+14,633% +$525K 0.01% 324
2023
Q3
$3.37K Hold
9
﹤0.01% 1034
2023
Q2
$2.94K Hold
9
﹤0.01% 1037
2023
Q1
$2.27K Hold
9
﹤0.01% 971
2022
Q4
$2.16K Hold
9
﹤0.01% 1010
2022
Q3
$2K Hold
9
﹤0.01% 1051
2022
Q2
$1.87K Buy
+9
New +$1.97K ﹤0.01% 1185

Other funds holding LII

Bartlett & Co Wealth Management's LII Position: Q2 2026 in Review

Bartlett & Co Wealth Management reduced its Lennox International (LII) stake by 78% in Q2 2026, selling an estimated $3.56K and leaving 2 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #1206.

Bartlett & Co Wealth Management first reported a position in LII in Q2 2022 and has held it in 17 quarters since. The position peaked at $595K in Q4 2023. 653 funds tracked by Wall St. Rank hold LII as of Q2 2026.

  • Bartlett & Co Wealth Management held 2 shares of Lennox International worth $1.15K as of Q2 2026.
  • Bartlett & Co Wealth Management sold 7 Lennox International shares in Q2 2026, an estimated $3.56K.
  • Lennox International made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #1206 holding.
  • Bartlett & Co Wealth Management first reported a position in Lennox International in Q2 2022 and has held it in 17 quarters since.
  • Bartlett & Co Wealth Management's Lennox International position peaked at $595K in Q4 2023.
  • 653 funds tracked by Wall St. Rank held Lennox International as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.